Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease-Reference-Cited by-同舟云学术

Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease

Published:2018-10-18 Issue:12 Volume:22 Page:6249-6261
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Huang Li¹^ORCID,Li Li²,Yang Tao¹,Li Wen¹,Song Li³,Meng Xianmin³,Gu Qing¹,Xiong Changming¹,He Jianguo¹

Affiliation:

1. Center of Pulmonary Vascular Disease; State Key Laboratory of Cardiovascular Disease; Fuwai Hospital; National Center for Cardiovascular Diseases; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

2. Department of Pathology; State Key Laboratory of Cardiovascular Disease; Fuwai Hospital; National Center for Cardiovascular Diseases; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

3. State Key Laboratory of Cardiovascular Disease; Fuwai Hospital; National Center for Cardiovascular Diseases; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.13912/fullpdf

Reference44 articles.

1. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry;Duffels;Int J Cardiol,2007

2. Pulmonary arterial hypertension in adults born with a heart septal defect: the EuroHeart Survey on adult congenital heart disease;Engelfriet;Heart,2007

3. How common is severe pulmonary hypertension after pediatric cardiac surgery?;Lindberg;J Thorac Cardiovasc Surg,2002

4. Screening study of pulmonary arterial hypertension in patients with congenital heart diseases;Sun;Zhonghua Yi Xue Za Zhi,2012

5. Current era survival of patients with pulmonary arterial hyper- tension (PAH) associate with congenital heart disease (CHD);Palazzini;Eur Heart J,2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification;European Heart Journal;2024-05-17

2. Differentially Expressed Genes and Pathways between Reversible and Irreversible Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Investigated by Bioinformatics Analysis in Rat Model;2023-09-05

3. Screening and identification of key biomarkers in diabetic kidney disease and its complications: Evidence from bioinformatics and next generation sequencing data analysis;2023-04-18

4. Pulmonary arterial hypertension associated with congenital heart disease: An omics study;Frontiers in Cardiovascular Medicine;2023-03-10

5. Deficiency of filamin A in smooth muscle cells protects against hypoxia‑mediated pulmonary hypertension in mice;International Journal of Molecular Medicine;2023-01-26